Alessandro Pancrazzi

6.5k total citations
42 papers, 2.5k citations indexed

About

Alessandro Pancrazzi is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Alessandro Pancrazzi has authored 42 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 27 papers in Hematology and 17 papers in Molecular Biology. Recurrent topics in Alessandro Pancrazzi's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Acute Myeloid Leukemia Research (16 papers) and Eosinophilic Disorders and Syndromes (14 papers). Alessandro Pancrazzi is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Acute Myeloid Leukemia Research (16 papers) and Eosinophilic Disorders and Syndromes (14 papers). Alessandro Pancrazzi collaborates with scholars based in Italy, United States and Spain. Alessandro Pancrazzi's co-authors include Alessandro M. Vannucchi, Paola Guglielmelli, Alberto Bosi, Elisabetta Antonioli, Giada Rotunno, Costanza Bogani, Lisa Pieri, Vanessa Ponziani, Tiziana Fanelli and Annalisa Pacilli and has published in prestigious journals such as Blood, American Journal Of Pathology and British Journal of Cancer.

In The Last Decade

Alessandro Pancrazzi

42 papers receiving 2.5k citations

Peers

Countries citing papers authored by Alessandro Pancrazzi

Since Specialization

Citations

This map shows the geographic impact of Alessandro Pancrazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Pancrazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Pancrazzi more than expected).

Fields of papers citing papers by Alessandro Pancrazzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Pancrazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Pancrazzi. The network helps show where Alessandro Pancrazzi may publish in the future.

Co-authorship network of co-authors of Alessandro Pancrazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Pancrazzi. A scholar is included among the top collaborators of Alessandro Pancrazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Pancrazzi. Alessandro Pancrazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lab tests for MPN 2021 ·International review of cell and molecular biology ·Alice Moncada, Alessandro Pancrazzi	2
2	Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator 2020 ·Clinica Chimica Acta ·Agostino Ognibene, Maria Lorubbio, (unknown), (unknown), (unknown), (unknown), Marco Feri, Raffaele Scala, (unknown), (unknown), Alessandro Pancrazzi, Danilo Tacconi	37
3	Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 2018 ·Blood Cancer Journal ·Annalisa Pacilli, Giada Rotunno, Carmela Mannarelli, Tiziana Fanelli, Alessandro Pancrazzi, Elisa Contini, Francesco Mannelli, Francesca Gesullo, Niccolò Bartalucci, (unknown), Chiara Paoli, Alessandro M. Vannucchi, Paola Guglielmelli	24
4	Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis 2017 ·Blood ·Paola Guglielmelli, Annalisa Pacilli, Giada Rotunno, Elisa Rumi, Vittorio Rosti, Federica Delaini, Margherita Maffioli, Tiziana Fanelli, Alessandro Pancrazzi, Daniela Pietra, Silvia Salmoiraghi, Carmela Mannarelli, (unknown), Chiara Paoli, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi	111
5	Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders–A consensus project of the Italian Society of Hematology 2017 ·Leukemia Research ·Paola Guglielmelli, Daniela Pietra, Fabrizio Pane, Alessandro Pancrazzi, Mario Cazzola, Alessandro M. Vannucchi, S Tura, Giovanni Barosi	17
6	CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients 2014 ·Leukemia ·Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Christy M. Finke, C Mannarelli, Alem A. Belachew, Alessandro Pancrazzi, Emnet A Wassie, Rhett P. Ketterling, Curtis A. Hanson, Animesh Pardanani, Alessandro M. Vannucchi	199
7	Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 2013 ·Leukemia ·(unknown), Elena Tenedini, Isabella Bernardis, Valentina Artusi, Lucia Artuso, Enrica Roncaglia, Paola Guglielmelli, Lisa Pieri, Costanza Bogani, Flavia Biamonte, Giada Rotunno, C Mannarelli, Elisa Bianchi, Alessandro Pancrazzi, Tiziana Fanelli, Guidantonio Malagoli Tagliazucchi, Sérgio Ferrari, Rossella Manfredini, Alessandro M. Vannucchi, Enrico Tagliafico	58
8	Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients 2011 ·Leukemia ·Animesh Pardanani, Paola Guglielmelli, Terra L. Lasho, Alessandro Pancrazzi, Christy M. Finke, Alessandro M. Vannucchi, Ayalew Tefferi	50
9	CXCR4‐independent rescue of the myeloproliferative defect of the gata1^low myelofibrosis mouse model by Aplidin® 2010 ·Journal of Cellular Physiology ·(unknown), Alessandro Pancrazzi, Miguel Aracil, Fabrizio Martelli, Paola Guglielmelli, Maria Zingariello, Barbara Ghinassi, Emanuela D’Amore, José Jimeno, Alessandro M. Vannucchi, Anna Ritá Migliaccio	18
10	Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3 2010 ·Haematologica ·Tiziano Barbui, Alessandra Carobbio, Guido Finazzi, Alessandro M. Vannucchi, Giovanni Barosi, Elisabetta Antonioli, Paola Guglielmelli, Alessandro Pancrazzi, Silvia Salmoiraghi, (unknown), Cosimo Ottomano, Roberto Marchioli, Ivan Cuccovillo, Barbara Bottazzi, Alberto Mantovani, Alessandro Rambaldi, (unknown)	143
11	A Sensitive Detection Method for MPLW515L or MPLW515K Mutation in Chronic Myeloproliferative Disorders with Locked Nucleic Acid-Modified Probes and Real-Time Polymerase Chain Reaction 2008 ·Journal of Molecular Diagnostics ·Alessandro Pancrazzi, Paola Guglielmelli, Vanessa Ponziani, Gaetano Bergamaschi, Alberto Bosi, Giovanni Barosi, Alessandro M. Vannucchi	35
12	MicroRNA expression profile in granulocytes from primary myelofibrosis patients 2007 ·Experimental Hematology ·Paola Guglielmelli, Lorenzo Tozzi, Alessandro Pancrazzi, Costanza Bogani, Elisabetta Antonioli, Vanessa Ponziani, G Poli, Roberta Zini, Sérgio Ferrari, Rossella Manfredini, Alberto Bosi, Alessandro M. Vannucchi	61
13	Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden 2007 ·Leukemia ·Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli, Giovanni Longo, Alessandro Pancrazzi, Vanessa Ponziani, Costanza Bogani, Pierluigi Rossi Ferrini, Alessandro Rambaldi, Vittoria Guerini, Alberto Bosi, Tiziano Barbui	279
14	Anaemia characterises patients with myelofibrosis harbouring Mpl^W515L/K mutation 2007 ·British Journal of Haematology ·Paola Guglielmelli, Alessandro Pancrazzi, Gaetano Bergamaschi, Vittorio Rosti, Laura Villani, Elisabetta Antonioli, Alberto Bosi, Giovanni Barosi, Alessandro M. Vannucchi	103
15	Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia 2007 ·Haematologica ·Elisabetta Antonioli, Paola Guglielmelli, G Poli, Costanza Bogani, Alessandro Pancrazzi, Giovanni Longo, Vanessa Ponziani, Lorenzo Tozzi, Lisa Pieri, Valeria Santini, Alberto Bosi, Alessandro M. Vannucchi	119
16	A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis 2006 ·Leukemia ·Alessandro M. Vannucchi, Alessandro Pancrazzi, Costanza Bogani, Elisabetta Antonioli, Paola Guglielmelli	54
17	Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086 2006 ·British Journal of Cancer ·Cristina Cellai, Anna Laurenzana, Alessandro M. Vannucchi, Roberto Caporale, Milena Paglierani, Simonetta Di Lollo, Alessandro Pancrazzi, Francesco Paoletti	29
18	WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential 2005 ·Leukemia ·Anna Laurenzana, Cristina Cellai, Alessandro M. Vannucchi, Alessandro Pancrazzi, María Novella Romanelli, Francesco Paoletti	11
19	PRV‐1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia 2004 ·British Journal of Haematology ·Alessandro M. Vannucchi, Alberto Grossi, Alessandro Pancrazzi, Elisabetta Antonioli, Paola Guglielmelli, (unknown), (unknown), (unknown), Giovanni Longo, Claudio Graziano, Luigi Gugliotta, Alberto Bosi	16
20	Internal Tandem Duplications ofFlt3Gene (Flt3/ITD) Predicts a Poor Post-Remission Outcome in Adult Patients with Acute Non-Promyelocytic Leukemia 2003 ·Leukemia & lymphoma ·(unknown), A. M. Vannucchi, Fabiana Leoni, Chiara Nozzoli, Giovanni Longo, (unknown), Alessandro Pancrazzi, Luís Bianchi, (unknown), Alberto Bosi	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact